Hakon Leffler

Active 1979–2025

121
Papers
19,857
Citations
84
h-index
118
i10-index

Citations

Citations per year for Hakon Leffler1936: 2 citations1978: 1 citations1980: 2 citations1981: 12 citations1982: 16 citations1983: 25 citations1984: 26 citations1985: 33 citations1986: 39 citations1987: 65 citations1988: 45 citations1989: 31 citations1990: 36 citations1991: 60 citations1992: 44 citations1993: 63 citations1994: 68 citations1995: 116 citations1996: 91 citations1997: 141 citations1998: 143 citations1999: 135 citations2000: 156 citations2001: 156 citations2002: 229 citations2003: 142 citations2004: 153 citations2005: 184 citations2006: 127 citations2007: 137 citations2008: 170 citations2009: 158 citations2010: 161 citations2011: 135 citations2012: 120 citations2013: 93 citations2014: 128 citations2015: 100 citations2016: 160 citations2017: 114 citations2018: 164 citations2019: 477 citations2020: 547 citations2021: 496 citations2022: 383 citations2023: 384 citations2024: 540 citations2025: 225 citations2026: 6 citations1937–1977: no citations, so these years are not shown1979: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,435 citing papers, 26.9% of this breakdownChina: 434 citing papers, 8.1% of this breakdownSweden: 358 citing papers, 6.7% of this breakdownGermany: 338 citing papers, 6.3% of this breakdownUnited Kingdom: 311 citing papers, 5.8% of this breakdownJapan: 280 citing papers, 5.3% of this breakdownFrance: 208 citing papers, 3.9% of this breakdownCanada: 159 citing papers, 3% of this breakdownNetherlands: 158 citing papers, 3% of this breakdownItaly: 138 citing papers, 2.6% of this breakdownSpain: 130 citing papers, 2.4% of this breakdownDenmark: 114 citing papers, 2.1% of this breakdown
0%26.9%Other 23.9%

Fields

  • Immunology and Microbiology40.8%
  • Biochemistry, Genetics and Molecular Biology25.9%
  • Medicine22.4%
  • Neuroscience3.5%
  • Chemistry1.5%
  • Agricultural and Biological Sciences1.4%
  • Other4.5%

Topics

  • Galectins and Cancer Biology14.3%
  • Glycosylation and Glycoproteins Research9.1%
  • Signaling Pathways in Disease3.9%
  • Toxin Mechanisms and Immunotoxins2.9%
  • Peptidase Inhibition and Analysis2.2%
  • Escherichia coli research studies2.2%
  • Other65.4%

Coauthors

All papers

Open in search
  1. Galectins at a glance

    Authors: , , - Journal of Cell Science 2018 cited by 613

  2. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2019 cited by 370

  3. Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2020 cited by 219

  4. Galectin-3, a marker for vacuole lysis by invasive pathogens

    Authors: , , , , , , , , , , - Cellular Microbiology 2009 cited by 383

  5. Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3

    Authors: , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2011 cited by 521

  6. Galectins: A family of animal β-galactoside-binding lectins

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell 1994 cited by 1,207

  7. Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation

    Authors: , , , , , , , , , , , , , , , , , , , - Cell Reports 2015 cited by 357

  8. Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease

    Authors: , , , , , , , , , , , , , - Journal of Medicinal Chemistry 2022 cited by 92

  9. Galectins. Structure and function of a large family of animal lectins.

    Authors: , , , - Journal of Biological Chemistry 1994 cited by 1,496

  10. An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade

    Authors: , , , , , , , , , , , , , , , , , - Cancer Research 2019 cited by 141

  11. Interplay between Conformational Entropy and Solvation Entropy in Protein–Ligand Binding

    Authors: , , , , , , , , , , , - Journal of the American Chemical Society 2019 cited by 138

  12. X-ray Crystal Structure of the Human Galectin-3 Carbohydrate Recognition Domain at 2.1-Å Resolution

    Authors: , , , , , - Journal of Biological Chemistry 1998 cited by 422

  13. Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants

    Authors: , , , , , , , , , , , , , - Cancer Chemotherapy and Pharmacology 2023 cited by 40

  14. Galectin-1, -2, and -3 Exhibit Differential Recognition of Sialylated Glycans and Blood Group Antigens

    Authors: , , , , , , , - Journal of Biological Chemistry 2008 cited by 417

  15. The Carbohydrate-Binding Site in Galectin-3 Is Preorganized To Recognize a Sugarlike Framework of Oxygens: Ultra-High-Resolution Structures and Water Dynamics

    Authors: , , , , , , , , , , - Biochemistry 2011 cited by 162

  16. Ligand Induced Galectin-3 Protein Self-association

    Authors: , , , - Journal of Biological Chemistry 2012 cited by 161

  17. Monosaccharide Derivatives with Low‐Nanomolar Lectin Affinity and High Selectivity Based on Combined Fluorine–Amide, Phenyl–Arginine, Sulfur–π, and Halogen Bond Interactions

    Authors: , , , , , , , - ChemMedChem 2017 cited by 106

  18. Extracellular and intracellular small-molecule galectin-3 inhibitors

    Authors: , , , , , , , , , - Scientific Reports 2019 cited by 105

  19. Galectin-9 Signaling Drives Breast Cancer Invasion through Extracellular Matrix

    Authors: , , , , , , , , , , - ACS Chemical Biology 2022 cited by 31

  20. Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity

    Authors: , , , , , , , , , , , - Journal of Medicinal Chemistry 2017 cited by 99

  21. Entropy–Entropy Compensation between the Protein, Ligand, and Solvent Degrees of Freedom Fine-Tunes Affinity in Ligand Binding to Galectin-3C

    Authors: , , , , , , , , , , , , , - JACS Au 2021 cited by 52

  22. Galectin‐3‐Binding Glycomimetics that Strongly Reduce Bleomycin‐Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition

    Authors: , , , , , , , , , , , , , , , , , , , - ChemBioChem 2016 cited by 198

  23. 1H-1,2,3-Triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors

    Authors: , , , , - Bioorganic & Medicinal Chemistry 2010 cited by 114

  24. Crosstalk between WNT and STAT3 is mediated by galectin-3 in tumor progression

    Authors: , , , , , , , , , , , - Gastric Cancer 2021 cited by 40